Presentation given as part of the panel at GCV Symposium London 23 May 2017 Panel included Bill Taranto Merck Global Health Innovation Jacqueline Lesage-Krause MunichRE David Mayhew GE Ventures Geoff McGrath McLaren Applied Technologies Andrew Gaule Aimava and GCV Academy